[DOI] [PMC free article] [PubMed] 6.Team TE
Most injection site reactions from compromised medication are mild and self-limiting, but medical evaluation ensures nothing serious is developing
BPC-157 also has the potential to enhance the function of the digestive tract and prevent against irritable bowel syndrome (IBS), gastrointestinal cramps, and Crohns disease
Use proper sterile technique to maintain solution integrity
While human clinical trials remain limited, the extensive body of animal research suggests potential applications in gastrointestinal healing, tendon and ligament repair, muscle recovery, neuroprotection, and cardiovascular health
Stability & Half-Life Data BPC-157 plasma half-life: Approximately 30 minutes following subcutaneous administration in rodent pharmacokinetic studies